Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,124 public trials 392 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B

NCT00002306

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +26 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • George Washington Univ Med Ctr Washington D.C., District of Columbia, United States
  • Univ of South Florida Tampa, Florida, United States
  • Emory Univ School of Medicine Atlanta, Georgia, United States
View all 14 locations
View Trial Details
Completed

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

NCT00002324

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • UCSD Treatment Ctr San Diego, California, United States
  • Saint Francis Mem Hosp San Francisco, California, United States
  • Wilmington Hosp Wilmington, Delaware, United States
  • Community Research Initiative of South Florida Coral Gables, Florida, United States
View all 18 locations
View Trial Details
Completed

A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations

NCT00002430

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama School of Med Montgomery, Alabama, United States
  • Ocean View Internal Medicine Long Beach, California, United States
  • AIDS Healthcare Foundation Los Angeles, California, United States
  • Tower ID Med Associates Los Angeles, California, United States
View all 46 locations
View Trial Details
Completed

A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)

NCT00001021

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • St Louis Univ School of Medicine St Louis, Missouri, United States
  • Univ of Rochester Med Ctr Rochester, New York, United States
  • Vanderbilt Univ Hosp Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine

NCT00002333

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Kaiser Foundation Hosp Harbor City, California, United States
  • UCSD La Jolla, California, United States
  • UCLA School of Medicine Los Angeles, California, United States
  • CARE Ctr / UCLA Med Ctr Los Angeles, California, United States
View all 47 locations
View Trial Details
Completed

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

NCT00008528

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Body Positive Phoenix, Arizona, United States
  • Pacific Oaks Med Group Beverly Hills, California, United States
  • AIDS Healthcare Foundation Los Angeles, California, United States
View all 37 locations
View Trial Details

Related conditions